Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1910 entries
Sorted by: Best Match Show Resources per page
Satellite cell activity is differentially affected by contraction mode in human muscle following a work-matched bout of exercise.

Frontiers in physiology

Hyldahl RD, Olson T, Welling T, Groscost L, Parcell AC.
PMID: 25566087
Front Physiol. 2014 Dec 11;5:485. doi: 10.3389/fphys.2014.00485. eCollection 2014.

Optimal repair and adaptation of skeletal muscle is facilitated by resident stem cells (satellite cells). To understand how different exercise modes influence satellite cell dynamics, we measured satellite cell activity in conjunction with markers of muscle damage and inflammation...

Cite
Hyldahl RD, Olson T, Welling T, et al. Satellite cell activity is differentially affected by contraction mode in human muscle following a work-matched bout of exercise. Front Physiol. 2014;5:485doi: 10.3389/fphys.2014.00485.
Hyldahl, R. D., Olson, T., Welling, T., Groscost, L., & Parcell, A. C. (2014). Satellite cell activity is differentially affected by contraction mode in human muscle following a work-matched bout of exercise. Frontiers in physiology, 5485. https://doi.org/10.3389/fphys.2014.00485
Hyldahl, Robert D, et al. "Satellite cell activity is differentially affected by contraction mode in human muscle following a work-matched bout of exercise." Frontiers in physiology vol. 5 (2014): 485. doi: https://doi.org/10.3389/fphys.2014.00485
Hyldahl RD, Olson T, Welling T, Groscost L, Parcell AC. Satellite cell activity is differentially affected by contraction mode in human muscle following a work-matched bout of exercise. Front Physiol. 2014 Dec 11;5:485. doi: 10.3389/fphys.2014.00485. eCollection 2014. PMID: 25566087; PMCID: PMC4263080.
Copy Download .nbib Format: NLM
Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review.

Medical mycology case reports

Parcell BJ, B C Raju PK, Johnson EM, Fardon TC, Olver WJ.
PMID: 24624325
Med Mycol Case Rep. 2014 Feb 10;4:12-5. doi: 10.1016/j.mmcr.2014.01.003. eCollection 2014 Apr.

The use of extracorporeal membrane oxygenation (ECMO) for reversible pulmonary failure in critically ill patients has increased over the last few decades. Nosocomial infections are a major complication of ECMO and fungi have been found to be a common...

Cite
Parcell BJ, B C Raju PK, Johnson EM, et al. Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review. Med Mycol Case Rep. 2014;4:12-5doi: 10.1016/j.mmcr.2014.01.003.
Parcell, B. J., B C Raju, P. K., Johnson, E. M., Fardon, T. C., & Olver, W. J. (2014). Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review. Medical mycology case reports, 412-5. https://doi.org/10.1016/j.mmcr.2014.01.003
Parcell, Benjamin J, et al. "Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review." Medical mycology case reports vol. 4 (2014): 12-5. doi: https://doi.org/10.1016/j.mmcr.2014.01.003
Parcell BJ, B C Raju PK, Johnson EM, Fardon TC, Olver WJ. Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review. Med Mycol Case Rep. 2014 Feb 10;4:12-5. doi: 10.1016/j.mmcr.2014.01.003. eCollection 2014 Apr. PMID: 24624325; PMCID: PMC3950536.
Copy Download .nbib Format: NLM
Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients.

The open dentistry journal

Naganawa K, Takayama E, Adachi M, Mitsudo K, Iida M, Kamiya-Mizuno M, Kawaki H, Ichinose M, Motohashi M, Muramatsu Y, Tohnai I, Sumitomo S, Shikimori M, Kondoh N.
PMID: 25893021
Open Dent J. 2015 Mar 31;9:120-4. doi: 10.2174/1874210601509010120. eCollection 2015.

In order to evaluate the Th1 and Th2 responses of Oral Squamous Cell Carcinoma (OSCC) patients, we investigated the cytokine producing capability of peripheral blood (PB), and compared it with clinicopathological appearances of OSCC patients. The production of a...

Cite
Naganawa K, Takayama E, Adachi M, et al. Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients. Open Dent J. 2015;9:120-4doi: 10.2174/1874210601509010120.
Naganawa, K., Takayama, E., Adachi, M., Mitsudo, K., Iida, M., Kamiya-Mizuno, M., Kawaki, H., Ichinose, M., Motohashi, M., Muramatsu, Y., Tohnai, I., Sumitomo, S., Shikimori, M., & Kondoh, N. (2015). Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients. The open dentistry journal, 9120-4. https://doi.org/10.2174/1874210601509010120
Naganawa, Kosuke, et al. "Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients." The open dentistry journal vol. 9 (2015): 120-4. doi: https://doi.org/10.2174/1874210601509010120
Naganawa K, Takayama E, Adachi M, Mitsudo K, Iida M, Kamiya-Mizuno M, Kawaki H, Ichinose M, Motohashi M, Muramatsu Y, Tohnai I, Sumitomo S, Shikimori M, Kondoh N. Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients. Open Dent J. 2015 Mar 31;9:120-4. doi: 10.2174/1874210601509010120. eCollection 2015. PMID: 25893021; PMCID: PMC4397950.
Copy Download .nbib Format: NLM
Interferon-gamma release assays.

Clinics in laboratory medicine

Belknap R, Daley CL.
PMID: 24856531
Clin Lab Med. 2014 Jun;34(2):337-49. doi: 10.1016/j.cll.2014.02.007. Epub 2014 Apr 12.

Diagnosis of latent tuberculosis infection (LTBI) should be targeted toward individuals and groups with high risk of progression to active tuberculosis (TB). Low-risk populations should not be screened. Interferon-gamma release assays (IGRAs) perform as well or better than the...

Cite
Belknap R, Daley CL. Interferon-gamma release assays. Clin Lab Med. 2014;34(2):337-49doi: 10.1016/j.cll.2014.02.007.
Belknap, R., & Daley, C. L. (2014). Interferon-gamma release assays. Clinics in laboratory medicine, 34(2), 337-49. https://doi.org/10.1016/j.cll.2014.02.007
Belknap, Robert, and Daley, Charles L. "Interferon-gamma release assays." Clinics in laboratory medicine vol. 34,2 (2014): 337-49. doi: https://doi.org/10.1016/j.cll.2014.02.007
Belknap R, Daley CL. Interferon-gamma release assays. Clin Lab Med. 2014 Jun;34(2):337-49. doi: 10.1016/j.cll.2014.02.007. Epub 2014 Apr 12. PMID: 24856531.
Copy Download .nbib Format: NLM
Effects of omega-3 fatty acids on regulatory T cells in hematologic neoplasms.

Revista brasileira de hematologia e hemoterapia

Betiati Dda S, de Oliveira PF, Camargo Cde Q, Nunes EA, Trindade EB.
PMID: 23741190
Rev Bras Hematol Hemoter. 2013;35(2):119-25. doi: 10.5581/1516-8484.20130033.

The development of leukemia and lymphomas is related to the increase in inflammatory process modulators. These, in turn, have divergent actions on the neoplastic process. Populations of T cells have different roles in the neoplastic environment; while interferon-gamma positive...

Cite
Betiati Dda S, de Oliveira PF, Camargo Cde Q, et al. Effects of omega-3 fatty acids on regulatory T cells in hematologic neoplasms. Rev Bras Hematol Hemoter. 2013;35(2):119-25doi: 10.5581/1516-8484.20130033.
Betiati, D. d. a. . S., de Oliveira, P. F., Camargo, C. d. e. . Q., Nunes, E. A., & Trindade, E. B. (2013). Effects of omega-3 fatty acids on regulatory T cells in hematologic neoplasms. Revista brasileira de hematologia e hemoterapia, 35(2), 119-25. https://doi.org/10.5581/1516-8484.20130033
Betiati, Dayanne da Silva Borges, et al. "Effects of omega-3 fatty acids on regulatory T cells in hematologic neoplasms." Revista brasileira de hematologia e hemoterapia vol. 35,2 (2013): 119-25. doi: https://doi.org/10.5581/1516-8484.20130033
Betiati Dda S, de Oliveira PF, Camargo Cde Q, Nunes EA, Trindade EB. Effects of omega-3 fatty acids on regulatory T cells in hematologic neoplasms. Rev Bras Hematol Hemoter. 2013;35(2):119-25. doi: 10.5581/1516-8484.20130033. PMID: 23741190; PMCID: PMC3672122.
Copy Download .nbib Format: NLM
MOLECULAR CLONING, SEQUENCING, EXPRESSION AND BIOLOGICAL ACTIVITY OF GIANT PANDA (AILUROPODA MELANOLEUCA) INTERFERON-GAMMA.

Journal of immunoassay & immunochemistry

Zhu H, Wang WX, Wang BQ, Zhu XF, Wu XJ, Ma QY, Chen DK.
PMID: 24965219
J Immunoassay Immunochem. 2012 Jun 29; doi: 10.1080/15321819.2012.686469. Epub 2012 Jun 29.

The giant panda (Ailuropoda melanoleuca) is an endangered species and indigenous to China. Interferon-gamma (IFN-γ) is the only member of type □ IFN and is vital for the regulation of host adapted immunity and inflammatory response. Little is known...

Cite
Zhu H, Wang WX, Wang BQ, et al. MOLECULAR CLONING, SEQUENCING, EXPRESSION AND BIOLOGICAL ACTIVITY OF GIANT PANDA (AILUROPODA MELANOLEUCA) INTERFERON-GAMMA. J Immunoassay Immunochem. 2012;doi: 10.1080/15321819.2012.686469.
Zhu, H., Wang, W. X., Wang, B. Q., Zhu, X. F., Wu, X. J., Ma, Q. Y., & Chen, D. K. (2012). MOLECULAR CLONING, SEQUENCING, EXPRESSION AND BIOLOGICAL ACTIVITY OF GIANT PANDA (AILUROPODA MELANOLEUCA) INTERFERON-GAMMA. Journal of immunoassay & immunochemistry, . https://doi.org/10.1080/15321819.2012.686469
Zhu, Hui, et al. "MOLECULAR CLONING, SEQUENCING, EXPRESSION AND BIOLOGICAL ACTIVITY OF GIANT PANDA (AILUROPODA MELANOLEUCA) INTERFERON-GAMMA." Journal of immunoassay & immunochemistry vol. (2012). doi: https://doi.org/10.1080/15321819.2012.686469
Zhu H, Wang WX, Wang BQ, Zhu XF, Wu XJ, Ma QY, Chen DK. MOLECULAR CLONING, SEQUENCING, EXPRESSION AND BIOLOGICAL ACTIVITY OF GIANT PANDA (AILUROPODA MELANOLEUCA) INTERFERON-GAMMA. J Immunoassay Immunochem. 2012 Jun 29; doi: 10.1080/15321819.2012.686469. Epub 2012 Jun 29. PMID: 24965219.
Copy Download .nbib Format: NLM
Spectrum of Disease in Children Treated for Tuberculosis at a Tertiary Children's Hospital in Australia.

Journal of the Pediatric Infectious Diseases Society

Britton PN, Yeung V, Lowbridge C, Isaacs D, Marais BJ.
PMID: 26619476
J Pediatric Infect Dis Soc. 2013 Sep;2(3):224-31. doi: 10.1093/jpids/pit009. Epub 2013 Mar 13.

BACKGROUND: Tuberculosis (TB) notification rates in Australia have plateaued at a low level, but the pediatric disease burden remains poorly described. Child cases provide a marker of recent transmission and present unique diagnostic challenges.METHODS: We performed an audit of...

Cite
Britton PN, Yeung V, Lowbridge C, et al. Spectrum of Disease in Children Treated for Tuberculosis at a Tertiary Children's Hospital in Australia. J Pediatric Infect Dis Soc. 2013;2(3):224-31doi: 10.1093/jpids/pit009.
Britton, P. N., Yeung, V., Lowbridge, C., Isaacs, D., & Marais, B. J. (2013). Spectrum of Disease in Children Treated for Tuberculosis at a Tertiary Children's Hospital in Australia. Journal of the Pediatric Infectious Diseases Society, 2(3), 224-31. https://doi.org/10.1093/jpids/pit009
Britton, Philip N, et al. "Spectrum of Disease in Children Treated for Tuberculosis at a Tertiary Children's Hospital in Australia." Journal of the Pediatric Infectious Diseases Society vol. 2,3 (2013): 224-31. doi: https://doi.org/10.1093/jpids/pit009
Britton PN, Yeung V, Lowbridge C, Isaacs D, Marais BJ. Spectrum of Disease in Children Treated for Tuberculosis at a Tertiary Children's Hospital in Australia. J Pediatric Infect Dis Soc. 2013 Sep;2(3):224-31. doi: 10.1093/jpids/pit009. Epub 2013 Mar 13. PMID: 26619476.
Copy Download .nbib Format: NLM
A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-γ.

Respiratory medicine case reports

Nei T, Okabe M, Mikami I, Koizumi Y, Mase H, Matsuda K, Yamamoto T, Takeda S, Tanaka K, Dan K.
PMID: 26029606
Respir Med Case Rep. 2012 Dec 31;8:10-3. doi: 10.1016/j.rmcr.2012.11.003. eCollection 2013.

Disseminated non-tuberculous mycobacterium (dNTM) infection is rare in humans without human immunodeficiency virus (HIV) infection. Previous reports have shown autoantibodies to human interferon-gamma (IFN-γ), which play important roles in mycobacterium infection, in the sera of patients with non-HIV dNTM...

Cite
Nei T, Okabe M, Mikami I, et al. A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-γ. Respir Med Case Rep. 2012;8:10-3doi: 10.1016/j.rmcr.2012.11.003.
Nei, T., Okabe, M., Mikami, I., Koizumi, Y., Mase, H., Matsuda, K., Yamamoto, T., Takeda, S., Tanaka, K., & Dan, K. (2013). A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-γ. Respiratory medicine case reports, 810-3. https://doi.org/10.1016/j.rmcr.2012.11.003
Nei, Takahito, et al. "A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-γ." Respiratory medicine case reports vol. 8 (2013): 10-3. doi: https://doi.org/10.1016/j.rmcr.2012.11.003
Nei T, Okabe M, Mikami I, Koizumi Y, Mase H, Matsuda K, Yamamoto T, Takeda S, Tanaka K, Dan K. A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-γ. Respir Med Case Rep. 2012 Dec 31;8:10-3. doi: 10.1016/j.rmcr.2012.11.003. eCollection 2013. PMID: 26029606; PMCID: PMC3920570.
Copy Download .nbib Format: NLM
Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients.

Journal of cachexia, sarcopenia and muscle

Lerner L, Hayes TG, Tao N, Krieger B, Feng B, Wu Z, Nicoletti R, Chiu MI, Gyuris J, Garcia JM.
PMID: 26672741
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):317-24. doi: 10.1002/jcsm.12033. Epub 2015 Apr 30.

BACKGROUND: Cancer-related weight loss is associated with increased inflammation and decreased survival. The novel inflammatory mediator growth differentiation factor (GDF)15 is associated with poor prognosis in cancer but its role in cancer-related weight loss (C-WL) remains unclear. Our objective...

Cite
Lerner L, Hayes TG, Tao N, et al. Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. J Cachexia Sarcopenia Muscle. 2015;6(4):317-24doi: 10.1002/jcsm.12033.
Lerner, L., Hayes, T. G., Tao, N., Krieger, B., Feng, B., Wu, Z., Nicoletti, R., Chiu, M. I., Gyuris, J., & Garcia, J. M. (2015). Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. Journal of cachexia, sarcopenia and muscle, 6(4), 317-24. https://doi.org/10.1002/jcsm.12033
Lerner, Lorena, et al. "Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients." Journal of cachexia, sarcopenia and muscle vol. 6,4 (2015): 317-24. doi: https://doi.org/10.1002/jcsm.12033
Lerner L, Hayes TG, Tao N, Krieger B, Feng B, Wu Z, Nicoletti R, Chiu MI, Gyuris J, Garcia JM. Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):317-24. doi: 10.1002/jcsm.12033. Epub 2015 Apr 30. PMID: 26672741; PMCID: PMC4670740.
Copy Download .nbib Format: NLM
Determining the Latent Tuberculosis Infection by IFN - γ Elispot Assay in Healthcare Workers From University Hospitals of Shiraz, South West of Iran.

Iranian Red Crescent medical journal

Taheri M, Bazrafkan H, Habibagahi M.
PMID: 24349745
Iran Red Crescent Med J. 2013 Jun;15(6):477-82. doi: 10.5812/ircmj.3635. Epub 2013 Jun 05.

BACKGROUND: Classical screening methods are incapable to properly detect LTBI (Latent TB Infection) and HCWs (Healthcare Workers) are at the high risk of exposure. Only few reports estimated the prevalence of LTBI among Iranian HCWs and they mostly used...

Cite
Taheri M, Bazrafkan H, Habibagahi M. Determining the Latent Tuberculosis Infection by IFN - γ Elispot Assay in Healthcare Workers From University Hospitals of Shiraz, South West of Iran. Iran Red Crescent Med J. 2013;15(6):477-82doi: 10.5812/ircmj.3635.
Taheri, M., Bazrafkan, H., & Habibagahi, M. (2013). Determining the Latent Tuberculosis Infection by IFN - γ Elispot Assay in Healthcare Workers From University Hospitals of Shiraz, South West of Iran. Iranian Red Crescent medical journal, 15(6), 477-82. https://doi.org/10.5812/ircmj.3635
Taheri, Mohammad, et al. "Determining the Latent Tuberculosis Infection by IFN - γ Elispot Assay in Healthcare Workers From University Hospitals of Shiraz, South West of Iran." Iranian Red Crescent medical journal vol. 15,6 (2013): 477-82. doi: https://doi.org/10.5812/ircmj.3635
Taheri M, Bazrafkan H, Habibagahi M. Determining the Latent Tuberculosis Infection by IFN - γ Elispot Assay in Healthcare Workers From University Hospitals of Shiraz, South West of Iran. Iran Red Crescent Med J. 2013 Jun;15(6):477-82. doi: 10.5812/ircmj.3635. Epub 2013 Jun 05. PMID: 24349745; PMCID: PMC3840834.
Copy Download .nbib Format: NLM
Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease.

ARYA atherosclerosis

Enayati S, Seifirad S, Amiri P, Abolhalaj M, Mohammad-Amoli M.
PMID: 26715931
ARYA Atheroscler. 2015 Sep;11(5):267-74.

BACKGROUND: Several inflammatory mediators have been proposed to contribute to the pathogenesis of atherosclerosis. The aim of this study was to evaluate the quantitative expression of pro-inflammatory cytokines in un-stimulated peripheral blood mononuclear cell of patients with coronary artery...

Cite
Enayati S, Seifirad S, Amiri P, et al. Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease. ARYA Atheroscler. 2015;11(5):267-74
Enayati, S., Seifirad, S., Amiri, P., Abolhalaj, M., & Mohammad-Amoli, M. (2015). Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease. ARYA atherosclerosis, 11(5), 267-74.
Enayati, Samaneh, et al. "Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease." ARYA atherosclerosis vol. 11,5 (2015): 267-74.
Enayati S, Seifirad S, Amiri P, Abolhalaj M, Mohammad-Amoli M. Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease. ARYA Atheroscler. 2015 Sep;11(5):267-74. PMID: 26715931; PMCID: PMC4680074.
Copy Download .nbib Format: NLM
The diagnostic accuracy of acute phase proteins and proinflammatory cytokines in sheep with pneumonic pasteurellosis.

PeerJ

El-Deeb WM, Elmoslemany AM.
PMID: 27547520
PeerJ. 2016 Jul 19;4:e2161. doi: 10.7717/peerj.2161. eCollection 2016.

The goal of this study was to assess the diagnostic accuracy of acute phase proteins and proinflammatory cytokines in sheep with pneumonic pasteurellosis. Blood samples were collected from 56 sheep (36 naturally infected with Pasteurella multocida and 20 healthy...

Cite
El-Deeb WM, Elmoslemany AM. The diagnostic accuracy of acute phase proteins and proinflammatory cytokines in sheep with pneumonic pasteurellosis. PeerJ. 2016;4:e2161doi: 10.7717/peerj.2161.
El-Deeb, W. M., & Elmoslemany, A. M. (2016). The diagnostic accuracy of acute phase proteins and proinflammatory cytokines in sheep with pneumonic pasteurellosis. PeerJ, 4e2161. https://doi.org/10.7717/peerj.2161
El-Deeb, Wael M, and Elmoslemany, Ahmed M. "The diagnostic accuracy of acute phase proteins and proinflammatory cytokines in sheep with pneumonic pasteurellosis." PeerJ vol. 4 (2016): e2161. doi: https://doi.org/10.7717/peerj.2161
El-Deeb WM, Elmoslemany AM. The diagnostic accuracy of acute phase proteins and proinflammatory cytokines in sheep with pneumonic pasteurellosis. PeerJ. 2016 Jul 19;4:e2161. doi: 10.7717/peerj.2161. eCollection 2016. PMID: 27547520; PMCID: PMC4957991.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1910 entries